Clinical Trials Browser

OTHER × Glioblastoma × Basiliximab × Clear all

NCT02366728 2023-06-08

ELEVATE

Phase 2 Completed

64 enrolled 17 charts

Glioblastoma

NCT00626483 2021-03-09

REGULATe

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma